ENTX's free cash flow for Q1 2024 was $-1.86M. For the 2024 fiscal year, ENTX's free cash flow was decreased by $-7.40M and operating cash flow was $-1.86M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Operating Cash Flow	$ -7.56M	$ -7.31M	$ 72.00K	$ -9.06M	$ -10.56M	$ -8.92M
Investing Cash Flow	$ -6.00K	$ -17.00K	$ -102.00K	$ -17.00K	$ -53.00K	$ 3.95M
Financing Cash Flow	$ 6.07M	$ 6.04M	$ 13.00K	$ 25.38M	$ 4.05M	$ 12.65M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 49.88M	$ 11.09M	$ 72.00K	$ 24.96M	$ 8.66M	$ 15.19M
Income Tax Paid Supplemental Data	-	-	$ 165.00K	$ 2.00K	$ 89.00K	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	$ 6.62M	$ 6.62M	-	$ 21.80M	$ 3.98M	$ 12.53M
Issuance Of Debt	$ -580.00K	$ -580.00K	-	-	-	-
Repayment Of Debt	$ -580.00K	$ -580.00K	-	-	$ -136.00K	$ -114.00K
Free Cash Flow	$ -7.57M	$ -7.33M	$ 72.00K	$ -9.08M	$ -10.61M	$ -8.96M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Entera Bio Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing